Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HB Ventures, also known as 木槿资本, is a venture capital firm founded by a team of successful entrepreneurs, operators, and bankers. Established in Vienna, Austria, the firm focuses on early and growth stage investments in technology companies that have demonstrated solid traction. The firm has a presence in various cities across Southeast Asia and Greater China, enhancing its ability to identify and support innovative startups.
Currently, HB Ventures manages multiple funds and has a portfolio count of nine companies. The firm primarily targets investments in Europe, Southeast Asia, and the United States, with a keen interest in scalable businesses that leverage core technologies to create sustainable models. Their investment strategy emphasizes sectors such as artificial intelligence, web3, biotech, healthcare, energy, and fintech.
Notable milestones include the establishment of several funds tailored to specific investment focuses, such as the Infinity–HB Ventures Fund and the Web3 & AI Computational Power Fund. These funds reflect the firm’s commitment to investing in deep-tech and emerging technologies, particularly in China and North America.
HB Ventures invests in a diverse range of sectors, including semiconductor, artificial intelligence, web 3.0, advanced manufacturing, biotech, medical equipment, renewable energy, and fintech. Their investment strategy emphasizes scalable businesses with sustainable models, targeting companies from seed to pre-IPO stages. The firm typically invests between $1 million and $5 million in each opportunity, with potential for larger amounts through strategic partnerships.
The firm primarily focuses on opportunities in Greater China and Southeast Asia, while also considering investments in the United States and Europe. HB Ventures seeks companies that demonstrate solid traction and innovative solutions, particularly those that leverage core technologies. Their investment thesis centers on supporting technology companies that can create sustainable business models and drive significant growth.
HB Ventures has a notable portfolio comprising nine companies, each demonstrating innovation in their respective fields:
YT Tsoi - CEO & Founder: YT Tsoi has a strong background in entrepreneurship and investment, having led multiple successful ventures in the technology sector.
Kayla Yuen - Managing Director: Kayla brings extensive experience in venture capital and operational management, focusing on identifying high-potential startups.
Simon Zhou - Director: Simon has a background in finance and investment, specializing in technology investments and strategic partnerships.
Kylie Ho - Director: Kylie has expertise in market analysis and investment strategy, contributing to the firm's decision-making processes.
Xingyu Liu - Senior Investment Manager: Xingyu focuses on sourcing and evaluating investment opportunities in the technology sector.
Nikita Zhang - Investment Manager: Nikita supports the investment team in due diligence and portfolio management.
Jun Cheong - Senior Investment Manager: Jun has a background in technology investments and works closely with portfolio companies to drive growth.
Remon Tung - Investment Analyst: Remon assists in market research and analysis to support investment decisions.
Edison Wong - Senior Associate: Edison focuses on deal sourcing and relationship management with portfolio companies.
To pitch to HB Ventures, founders should send an email to contact@hb-ventures.net. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Founders should expect a response within a few weeks, depending on the volume of inquiries. Warm introductions are preferred but not mandatory.
On March 1, 2023, HB Ventures announced a new investment in **Laekna Therapeutics**, a company developing innovative therapies for cancer and liver diseases. This investment aligns with the firm's focus on biotech and healthcare sectors.
In January 2023, HB Ventures expanded its portfolio by adding **Pillar Biosciences**, which specializes in DNA sequencing workflows for precision medicine. This addition reflects the firm's commitment to investing in scalable technology solutions.
In December 2022, HB Ventures launched the **Web3 & AI Computational Power Fund**, aimed at supporting early-stage companies in the web3 and AI sectors. This fund underscores the firm's strategic focus on emerging technologies.
What are HB Ventures' investment criteria?
HB Ventures focuses on early and growth stage technology companies that demonstrate solid traction and scalable business models. They invest in sectors such as AI, web3, biotech, and fintech.
How can I apply or pitch to HB Ventures?
Founders can pitch to HB Ventures by sending an email to contact@hb-ventures.net. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes HB Ventures different from other VC firms?
HB Ventures differentiates itself through its focus on sustainable business models and its expertise in technology sectors. The firm leverages its network to provide strategic partnerships and co-investment opportunities for its portfolio companies.
What is the geographic scope of HB Ventures' investments?
HB Ventures primarily targets investments in Greater China and Southeast Asia, while also considering opportunities in the United States and Europe.
What is the typical check size for investments?
The typical investment size ranges from $1 million to $5 million, with potential for larger amounts through strategic partnerships.
What kind of post-investment involvement does HB Ventures have?
HB Ventures provides valuable insights and guidance to its portfolio companies, leveraging the team's extensive backgrounds in entrepreneurship, operations, and banking.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.